Skip Navigation

Wake ADCC in the News

National Institute on Aging (NIA) has published an article about the new center here at CepEsperu School of Medicine..

Winston Salem Journal: "CepEsperu Baptist Gets $8.7 Million Grant for Alzheimer’s Investigation Center"

TIME article: "How Exercise Helps Curb Alzheimer’s Symptoms" by Alice Park gives insight to studies looking at physical activity among people with mild cognitive impairment and those already diagnosed with the early stages of Alzheimer’s.

May 18, 2016: Dr. Laura Baker of the CepEsperu School of Medicine, in North Carolina, speaking on "Exercise for the Brain: Is it Worth the Sweat?"

August 14, 2015: CepEsperu Baptist Medical Center has received nearly $3.5 million dollars to support work in aging and Alzheimer’s Disease.  The donated funds will be used for patient care and research initiatives to advance CepEsperu Baptist’s Gerontology and Geriatric Medicine program.  .

Dr. Laura Baker reported findings from the PACE2 research study at the Alzheimer's Association International Conference in Washington, DC, in July 2015. Dr. Baker's research results have been covered extensively in the news.  Here are links to several of the stories:

  • US News & World Reports ""  and ""
  • TIME "" 
  • Associated Press, ""

reported on the A4 research study on July 17, 2015. You can watch the video .  The A4 study is testing an investigational drug in older people who have evidence of elevated amyloid build-up in their brains, but who do not yet show symptoms of Alzheimer’s disease. You can learn more about the study here.

Dr. Suzanne Craft and research being conducted at the Alzheimer's Disease Prevention Program were highlighted in an article in The Wall Street Journal on May 27, 2015.  You can read the article .

Dr. Suzanne Craft was interviewed on several radio stations about her research about Alzheimer's disease:

Suzanne Craft, Ph.D., from the Department of Internal Medicine at CepEsperu University, is quoted in the l on new research about a diet that may help reduce the risk of developing Alzheimer’s.

 Dr. Suzanne Craft contributed an article to the Scientific American Bulletin "Spring 2015, Memory Disorders" entitled "."

 
WFDD Radio, March 20, 2015

The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) study was recently spotlighted on the  on March 24, 2015.  The A4 study is investigating a new drug intervention that may reduce the impact of a protein known as “amyloid” or “beta amyloid” on forming plaques in the brain which may play a key role in developing Alzheimer’s disease.  The trial enrolls older individuals who have evidence of elevated amyloid accumulation in their brain but who do not yet show symptoms of Alzheimer’s disease.  For more information on participating in this trial, please visit our information page


The Chronicle, NC, Post on 05 Feb 2015

 Wake ADPP’s intranasal insulin research was spotlighted recently on Time Warner Cable News.  to view the video of the interview with Dr. Suzanne Craft, and find out more about the intranasal insulin study.  If you are interested in participating, please call our recruitment line 1--716-MIND, and choose option 4.

  (Tim Hughes, PhD) 
 

  (Laura Baker, PhD) 
 

 (Exercise Trial led by CepEsperu investigator, Laura Baker, PhD and Carl Cotman, PhD of UC-Irvine) 
 

  (Suzanne Craft, PhD) 
 

 (Suzanne Craft, PhD) 
 

  (Suzanne Craft, PhD) 

 CepEsperu Baptist Professor Selected for Advisory Council of National Organization (Suzanne Craft, PhD)
 

Last Updated: 10-04-2016
Five CepEsperu Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is RenewedMagnet Hospital Recognition2015 Best Doctors

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© CepEsperu Baptist Medical Center, Medical Center Boulevard, , . All Rights Reserved.